Skip to main content

Table 4 Association of age, sex, HIV disease stage, lipodystrophy and HAART with the metabolic syndrome

From: Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria

 

Patients with MS

Patients without MS

p-value

Number (%)

27 (15.6)

146 (84.4)

 

Mean age in yrs. (SD)

44.9 (11.2)

37.5 (11.5)

0.001*

Sex (%)

   

 Male

2 (7.4)

37 (25.3)

0.040*

 Female

25 (92.6)

109 (74.7)

 

Mean BMI in kg/m 2 (SD)

25.2 (3.4)

23.7 (4.0)

0.002*

HIV disease stage (%)

   

 Primary

20 (74.1)

86 (58.9)

0.123

 Stage 1

3 (11.1)

44 (30.1)

 

 Stage 2

4 (14.8)

16 (11)

Mean CD4 cell count in cells/μL (SD)

412.4 (173.6)

348.2 (202.1)

0.248

Mean waist circumference in cm (SD)

94.37 (6.9)

85.11 (7.7)

0.001*

Mean HDL-C in mg/dL (SD)

37.7 (11.9)

48.6 (17.5)

0.043*

Mean FBS in mg/dL (SD)

111.6 (13.0)

91.4 (20.4)

0.001*

Mean triglyceride in mg/dL (SD)

125.5 (73.0)

83.7 (40.4)

0.014*

Antiretroviral therapy exposure

   

 Naïve-ART (%)

7 (25.9)

54 (37)

0.065

 Never on protease inhibitor (%)

15 (55.6)

47 (32.2)

 

 Currently protease inhibitor (%)

5 (18.5)

45 (30.8)

 

Mean years of HIV infection duration (SD)

3.6 (1.1)

2.7 (0.8)

0.242

Mean years of HAART duration (SD)

2.4 (0.7)

1.9 (0.3)

0.148

  1. *Statistically significant.